From: Dugstr2 at ST... dwolf say... analysts = paid shillsDugstr2 17m $BB yesterday I missed the earnings call. Just listened to all of it on tge bb investors website. I paid particular attention to DavidJacks post earlier today, about Chen mentioning not to expect contracts with bb ivy till callender year 2023. My question is- are these analysts that ask the questions on drugs??? Who the hell would not immediately pick up on that , and ask about it? Bb ivy is - by far- the most important contingent that bb has going for it. That is not ment to demean tge other vertices that bb has. Its just that ivy potential is enormous.